![]() Bioxytran Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies. | ![]() Metabolomic Technologies Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
| ||
Founding Date | Founding Date 1993 | Founding Date 2008 | Founding Date 2010 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Holon, IL HQ South San Francisco, US | Locations Newton, US HQ Newton, US | Locations Edmonton, CA HQ Edmonton, CA |
Employees | Employees 74 | Employees 3 | Employees 3 |
Financial | |||
Net income | Net income $35.3m (FY, 2025) | Net income ($2.1m) (FY, 2025) | Net income N/A |

Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies.
View company
Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
View company